NTS-105 Decreases Cell Death After In Vitro Stretch Injury
This study demonstrated the ability of NTS-105 to reduce cell death at a wide range of concentrations in preclinical models of TBI.
Advancements in the Development of Novel Neurosteroids for Treatment of Brain Injury
This presentation will describe recent advances in the development of novel neurosteroids for the treatment of traumatic brain injury.
- Zhang, et al. (2022). Pharmacological characterization of a novel neuroactive steroid prodrug, NTS-104 and its neuroprotective activity in experimental stroke models. Stroke. https://www.ahajournals.org/doi/10.1161/STROKEAHA.122.038507
- Byrne, Robin, et al. (2022). Abstract WMP9: Pharmacological Characterization Of The Water Soluble Neurosteroid NTS-104 In The Rat Embolic Stroke Model. Stroke, 53(Suppl_1), AWMP9–AWMP9. https://doi.org/10.1161/str.53.suppl_1.WMP9
Comments are closed.